Abnormal platelet phenotypes in patients with myelodysplastic syndromes.

CONCLUSION: Myelodysplastic syndromes patients displayed defective expression of both activation- and immune-associated platelet phenotypes, with differential mechanisms between low-risk and high-risk groups regarding phenotype alterations. The findings confirmed impaired platelet phenotypes in MDS which may assist in the diagnosis and identification of MDS patients.
PMID: 32202052 [PubMed - as supplied by publisher]

Source: International Journal of Laboratory Hematology - March 22, 2020 Category: Hematology Authors: Liu J, Niu H, Yue L, Lv Q, Yang L, Liu C, Jiang H, Xing L, Shao Z, Wang H Tags: Int J Lab Hematol Source Type: research